ARCHIVES

In Brief: Cancer Panel To Meet In Seattle, Houston, Chicago; Wisconsin’s Robert Johnson Dies; Goldin Retires

This article is from The Cancer Letter archive.

Vol. 08 No. 33 | August 27, 1982

Download PDF Visit The Full Archive

Related Articles

Alan Rabson Named Acting NCI Director

October 5, 2001

Interim Analysis of Phase III Data Preferable For Accelerated Approval, FDA’s Pazdur Says

September 6, 2002

NIAID Advisors Ok Recompetition of Pediatric ACTGs

February 14, 1992

New Drug for Lymphoma Enters Phase II Trial

May 28, 2004

Health Reform Plans Offer Difficult Choices For Patients, Researchers, Practitioners

February 25, 1994

Senate Confirms McClellan For FDA

October 25, 2002